Laura N. Jeffreys

Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>

Laura N. Jeffreys, Alison Ardrey, Taghreed A. Hafiz et al. · ACS Infectious Diseases · 2023 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs

Laura N. Jeffreys, Harshwardhan Poddar, Marina Golovanova et al. · Scientific Reports · 2019 · 28 citations · Full text

Medicine, Biochemistry, Pharmacology +13

Characterization of Cytochrome P450 Enzymes and Their Applications in Synthetic Biology

Laura N. Jeffreys, Hazel M. Girvan, Kirsty J. McLean et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 2018 · 26 citations

Life Sciences, Biochemistry, Pharmacology +16

Remdesivir–ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2

Laura N. Jeffreys, Shaun H. Pennington, Jack Duggan et al. · International Journal of Antimicrobial Agents · 2022 · 24 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

Structural deformability induced in proteins of potential interest associated with COVID-19 by binding of homologues present in ivermectin: Comparative study based in elastic networks models

Lenin González-Paz, María Laura Hurtado-León, Carla Lossada et al. · Journal of Molecular Liquids · 2021 · 15 citations · Full text

Life Sciences, Biology, Infectious Diseases +16